Pharmacokinetic Study of Nilotinib in Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor Showing Failure to Both Imatinib and Sunitinib.
Phase of Trial: Phase II
Latest Information Update: 03 Jul 2013
At a glance
- Drugs Nilotinib (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Pharmacokinetics
- 16 Jul 2012 Actual end date (Dec 2011) added as reported by ClinicalTrials.gov.
- 28 Sep 2011 Planned end date changed from 1 Dec 2010 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 29 Jul 2010 Planned end date changed from Jun 2010 to Dec 2010 as reported by ClinicalTrials.gov.